The use of invasive placebo controls in clinical trials is a contentious issue. In an editorial, Allan Cyna and colleagues from the University of Adelaide in South Australia, describe why they think trials using invasive placebos should be excluded from Cochrane Reviews. This editorial is read by Rachel Marshall on behalf of the authors.

Read the Editorial here.